Ireland-based Vivasure Medical said today it launched its PerQseal closure device intended for large-bore transcatheter procedures.

The newly launched device is intended for novel transcatheter endovascular procedures including transcatheter aortic valve replacements, thoracic endovascular aneurysm repairs and endovascular abdominal aneurysm repairs, which require large-bore femoral artery access. The system consists of an intravascular patch to seal the vessel from the inside.

Vivasure Medical touted the PerQseal as the first sutureless, fully absorbable synthetic implant for large bore arterial punctures.

“Closing the artery has been a concern since we started using transcatheter techniques for valve implantation. The PerQseal device is a very innovative solution for closing large holes, and we are enthusiastic to make it part of our armamentarium,” Horst Sievert of Frankfurt, Germany’s CardioVascular Center said in a prepared statement.

“We’re excited that the PerQseal device is now widely available to European physicians, providing a safe and simple option for the closure of large puncture holes that leaves behind no sutures, metal implants, or collagen. This commercial launch is a key milestone for Vivasure as we journey to enable better patient outcomes in fully percutaneous large-bore endovascular procedures,” VivaSure Medical co-founder & CEO Gerard Brett said in a prepared release.